Form 4: NeuroOne Medical Technologies Director Sells Shares
SEC Form 4
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, sold 25,800 shares of common stock at an average price of $0.8784 on June 5, 2024.
Summary
- On June 5, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, sold 25,800 shares of common stock.
- The shares were sold at a weighted average price of $0.8784.
- The prices ranged from $0.8741 to $0.8801 per share.
- Following the transaction, Christianson directly owns 297,224 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative. It's a routine disclosure of an insider stock sale, which doesn't inherently indicate a positive outlook, but also isn't necessarily alarming without further context.
Industry Context
Insider sales are common and can be for various reasons, including diversification or personal financial planning. However, they are often scrutinized by investors as they may provide insight into management's perspective on the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 06/05/2024 | Date of transaction: Mark Christianson sold 25,800 shares of NMTC. |
| 06/07/2024 | Date of signature: Stephanie Swan signed the Form 4 on behalf of Mark Christianson. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.